News

Researchers from Helmholtz Munich and the Technical University of Munich have developed a novel method to track cancer ...
A breast cancer vaccine targeting a key protein showed strong immune responses in over 75 percent of its trial participants ...
New preclinical research shows a promising drug combination that targets ovarian cancer’s survival pathways, paving the way ...
A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may help explain why certain liver tumors return quickly after thermal ablation, a widely used ...
Tumors can destroy the blood vessels of muscles even when the muscles are nowhere close to the tumor. That is the key finding ...
DCIS is a non-invasive or pre-invasive breast cancer, meaning the cancer cells are confined to the milk ducts and haven’t ...
Scientists have discovered that a locally developed cancer drug, PRL3-zumab, may offer a groundbreaking treatment for two ...
Artificial intelligence is now designing custom proteins in seconds—a process that once took years—paving the way for cures to diseases like cancer and antibiotic-resistant infections. Australian ...
A University of Arizona cancer research lab, facing difficulties in getting federal funding, has started a crowdfunding ...
Landmark research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why some promising cancer treatments are causing serious side effects, and offers ...
New research reveals cancer cells generate “power waves” of energy helping them move, stretch, and invade more aggressively.